Drug Trade Secrets

In a revolutionary move, announced in August 1 issue of the New England Journal of Medicine, GS GlaxoSmithKline (GSK)  announced it would provide access to data from GSK-sponsored clinical trials to research teams at a special web site. .Data that drives decisions such as what medications are approved and used for women is typically obtained from successful trials. Medications in development who's clinical trials that are not clear, or show negative effects, typically wind up shelved. The actual has been considered private. In part because the companies investing money want to protect their research property, and explaining that too much data revealed can affect patient confidentiality, the companies have not wanted to make public access to research data. The British Medical Journal (BMJ)  began pushing for more transparent process to this research since this secret process essentially means that more data is not published than the data that is. Rebel researchers have been on their own push to get information out there with or without the blessing of the company who sponsored the trials. Often with new information, older data can be interpreted in a new light, and potentially lead to valuable discoveries. New calculations, and pairing trials together to get larger numbers are potentially ways researchers can answer questions cost effectively without starting trials from scratch, so the way has been paved to a new way gynos can gab with their patients. If you have questions about Clinical Trials or interest in participating in one you may want to register with the clinical research department at Women's Health Practice.


Popular posts from this blog

Passing Your Uterine Lining, Menstrual Period Norms

Mirena IUD and Your Sex Drive

Post-Endometrial Ablation Syndrome